Literature DB >> 24028296

Chronic obstructive pulmonary disease: a risk factor for type 2 diabetes: a nationwide population-based study.

Charles T-C Lee1, I-Chieh Mao, Ching-Hsiung Lin, Sheng-Hao Lin, Ming-Chia Hsieh.   

Abstract

BACKGROUND: Type 2 diabetes mellitus (DM) is a common medical disorder and a leading cause of morbidity and mortality worldwide. We investigated whether chronic obstructive pulmonary disease (COPD) was the risk factor for type 2 diabetes in an Asian population.
MATERIALS AND METHODS: From Taiwan's National Health Insurance Research Database, we collected data from 16,088 patients, including 8044 COPD patients and 8044 age- and gender- matched control subjects. Cox proportional hazard regression was performed to evaluate independent risk factors for type 2 diabetes in all patients and identify risk factors in patients with COPD.
RESULTS: During the 5.5-year follow-up, patients with COPD were found to have a significantly higher rate of incident type 2 diabetes than the control group (P < 0.001). COPD was significantly associated with type 2 diabetes hazard ratio (HR : 1.41, 1.23-1.63, P < 0.001) after adjusting sex, age, residential area, insurance premium, steroid use, hypertriglycemia, hypertension, coronary artery disease (CAD) and cerebrovascular disease. Cox regression analysis showed that hypertension (HR : 1.55, 1.33-1.80, P < 0.001) and hypertriglycemia (HR : 1.48, 1.15-1.90, P = 0.002) were important risk factors for type 2 diabetes in patients with COPD.
CONCLUSIONS: Patients with COPD have a higher risk of type 2 diabetes compared with control subjects after adjusting for confounding factors such as sex, age, residential area, insurance premium, steroid use, hypertriglycemia, hypertension, CAD and cerebrovascular disease. Continuous surveillance of signals of dysglycemia may be incorporated into care programmes for patients with COPD.
© 2013 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  COPD; type 2 diabetes

Mesh:

Year:  2013        PMID: 24028296     DOI: 10.1111/eci.12147

Source DB:  PubMed          Journal:  Eur J Clin Invest        ISSN: 0014-2972            Impact factor:   4.686


  20 in total

1.  Relationship Between C-Reactive Protein and Respiratory Diseases in Patients with Type 2 Diabetic Retinopathy.

Authors:  Kejia Chen; Jiamin Yan; Ling Wu; Xingbo Gu
Journal:  Med Sci Monit       Date:  2022-05-17

Review 2.  Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management.

Authors:  Nirupama Putcha; M Bradley Drummond; Robert A Wise; Nadia N Hansel
Journal:  Semin Respir Crit Care Med       Date:  2015-08-03       Impact factor: 3.119

3.  [Neutrophil to lymphocyte ratio as a predictor for type 2 diabetes mellitus in patients with chronic obstructive pulmonary disease: a cohort study of 404 cases].

Authors:  Tao Ye; Yin Yang; Kai Wang; Mei Wang; Jia Sun; Yue DU; Xin Chen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-10-20

4.  [The role of counterinsular hormones in the regulation of glucose homeostasis and the pathogenesis of type 2 diabetes mellitus in COPD].

Authors:  V I Kobylyansky
Journal:  Probl Endokrinol (Mosk)       Date:  2021-02-17

5.  The association between glucose levels and hospital outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease.

Authors:  Ebtesam A Islam; Chok Limsuwat; Teerapat Nantsupawat; Gilbert G Berdine; Kenneth M Nugent
Journal:  Ann Thorac Med       Date:  2015 Apr-Jun       Impact factor: 2.219

Review 6.  Metabolic Disorders in Chronic Lung Diseases.

Authors:  Ourania Papaioannou; Theodoros Karampitsakos; Ilianna Barbayianni; Serafeim Chrysikos; Nikos Xylourgidis; Vasilis Tzilas; Demosthenes Bouros; Vasilis Aidinis; Argyrios Tzouvelekis
Journal:  Front Med (Lausanne)       Date:  2018-01-18

7.  Diabetes risks and outcomes in chronic obstructive pulmonary disease patients: Two nationwide population-based retrospective cohort studies.

Authors:  Chao-Shun Lin; Chih-Chung Liu; Chun-Chieh Yeh; Yi-Cheng Chang; Chi-Li Chung; Hsin-Long Lane; Chun-Chuan Shih; Ta-Liang Chen; Chien-Chang Liao
Journal:  PLoS One       Date:  2017-08-16       Impact factor: 3.240

8.  Type 2 diabetes is associated with an increased prevalence of respiratory symptoms as compared to the general population.

Authors:  F De Santi; G Zoppini; F Locatelli; E Finocchio; V Cappa; M Dauriz; G Verlato
Journal:  BMC Pulm Med       Date:  2017-07-17       Impact factor: 3.317

9.  Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality.

Authors:  Te-Wei Ho; Chun-Ta Huang; Sheng-Yuan Ruan; Yi-Ju Tsai; Feipei Lai; Chong-Jen Yu
Journal:  PLoS One       Date:  2017-04-14       Impact factor: 3.240

10.  Chronic obstructive pulmonary disease, lung function and risk of type 2 diabetes: a systematic review and meta-analysis of cohort studies.

Authors:  Yang Peng; Guo-Chao Zhong; Lingxiao Wang; Lijuan Guan; Ao Wang; Kai Hu; Jing Shen
Journal:  BMC Pulm Med       Date:  2020-05-11       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.